NO905090L - Interleukin-1-inhibitorer og fremgangsmaate til deres fremstilling. - Google Patents

Interleukin-1-inhibitorer og fremgangsmaate til deres fremstilling.

Info

Publication number
NO905090L
NO905090L NO90905090A NO905090A NO905090L NO 905090 L NO905090 L NO 905090L NO 90905090 A NO90905090 A NO 90905090A NO 905090 A NO905090 A NO 905090A NO 905090 L NO905090 L NO 905090L
Authority
NO
Norway
Prior art keywords
interleukin
inhibitors
procedures
preparation
Prior art date
Application number
NO90905090A
Other languages
English (en)
Other versions
NO905090D0 (no
NO316122B1 (no
Inventor
Charles H Hannun
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of NO905090D0 publication Critical patent/NO905090D0/no
Publication of NO905090L publication Critical patent/NO905090L/no
Publication of NO316122B1 publication Critical patent/NO316122B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19905090A 1988-05-27 1990-11-23 DNA-sekvens som koder for interleukin-1-inhibitorer, rekombinant vektor sominneholder og kan kode DNA-sekvensen, vertcelle som inneholder ogkan uttrykkevektorer, og fremgangsmåte til fremstilling av interleukin-1-inhibitorer, og rekombinant vertcelle s NO316122B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
NO905090D0 NO905090D0 (no) 1990-11-23
NO905090L true NO905090L (no) 1991-01-28
NO316122B1 NO316122B1 (no) 2003-12-15

Family

ID=27394086

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19905090A NO316122B1 (no) 1988-05-27 1990-11-23 DNA-sekvens som koder for interleukin-1-inhibitorer, rekombinant vektor sominneholder og kan kode DNA-sekvensen, vertcelle som inneholder ogkan uttrykkevektorer, og fremgangsmåte til fremstilling av interleukin-1-inhibitorer, og rekombinant vertcelle s
NO20014783A NO316917B1 (no) 1988-05-27 2001-10-01 Fremgangsmate til fremstilling av et farmasoytisk preparat inneholdende en interleukin-1-inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20014783A NO316917B1 (no) 1988-05-27 2001-10-01 Fremgangsmate til fremstilling av et farmasoytisk preparat inneholdende en interleukin-1-inhibitor

Country Status (9)

Country Link
JP (2) JP3192651B2 (no)
KR (1) KR970002917B1 (no)
BR (1) BR8907457A (no)
DK (1) DK172763B1 (no)
FI (2) FI109206B (no)
HU (3) HU9803037D0 (no)
NO (2) NO316122B1 (no)
OA (1) OA09631A (no)
WO (1) WO1989011540A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5747444A (en) * 1990-10-09 1998-05-05 Chiron Corporation Method of treating graft-versus-host disease
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
US20060067938A1 (en) * 2001-10-26 2006-03-30 Sherif Daouti Methods for the treatment of osteoarthritis and compositions thereof
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
WO2009026303A1 (en) 2007-08-21 2009-02-26 Amgen Inc. Human c-fms antigen binding proteins
CN102209557A (zh) * 2008-09-12 2011-10-05 埃克斯生物科技公司 靶向病原性单核细胞
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
AU2012242666A1 (en) 2011-04-15 2013-11-28 Merck Patent Gmbh Anti- IL-1R1 inhibitors for use in cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
KR102380150B1 (ko) 2016-03-08 2022-03-29 얀센 바이오테크 인코포레이티드 Gitr 항체, 방법, 및 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法

Also Published As

Publication number Publication date
OA09631A (en) 1993-04-30
NO905090D0 (no) 1990-11-23
DK8591D0 (da) 1991-01-18
JP2001029093A (ja) 2001-02-06
AU633831B2 (en) 1993-02-11
DK172763B1 (da) 1999-07-05
WO1989011540A1 (en) 1989-11-30
NO20014783D0 (no) 2001-10-01
JPH03505279A (ja) 1991-11-21
NO20014783L (no) 1991-01-28
NO316122B1 (no) 2003-12-15
BR8907457A (pt) 1991-04-02
FI905812A0 (fi) 1990-11-26
FI109206B (fi) 2002-06-14
DK8591A (da) 1991-01-18
HU222810B1 (hu) 2003-11-28
NO316917B1 (no) 2004-06-21
HU893412D0 (en) 1991-05-28
HU9803037D0 (en) 1999-11-29
JP3192651B2 (ja) 2001-07-30
AU3746989A (en) 1989-12-12
HU215434B (hu) 1999-04-28
FI20020545A (fi) 2002-03-21
KR970002917B1 (ko) 1997-03-12

Similar Documents

Publication Publication Date Title
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO905090L (no) Interleukin-1-inhibitorer og fremgangsmaate til deres fremstilling.
DK641589A (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
DK242389A (da) Hydroxamatderivater og fremgangsmaade til fremstilling deraf
NO873640L (no) Nye cefemforbindelser og fremgangsmaate til deres fremstilling.
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
NO894624L (no) Kopolymerer og fremgangsmaate for deres fremstilling.
NO893886L (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
DK631587D0 (da) Imidazolderivater og fremgangsmaade til deres fremstilling
DK409886D0 (da) Azolyl-cyclopropyl-ethanol-derivater, fremgangsmaade til deres fremstilling og deres anvendelse
DK530689A (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
DK651087D0 (da) Renininhibitorer iii, deres fremstilling og anvendelse
DK360189A (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
NO883114L (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
DK103889A (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
NO881777D0 (no) Benzensulfonamidderivater og fremgangsmaate til deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
DK390287A (da) Cephalosporiner og derivater deraf samt fremgangsmaader til deres fremstilling

Legal Events

Date Code Title Description
LC4 Limitation of patent rights - b3 (par. 39b patent act)
MK1K Patent expired